Altimmune, Inc. (ALT) Tops Q4 EPS by 1c
Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.